Search
for
Sort by
Research 151–180 of 358
- Comparison between low-dose chemotherapy and surgery for the treatment of extremity-associated solitary bone lesions in children with Langerhans cell histiocytosis in South China: A case-control study
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Expression patterns of MITF during human cutaneous embryogenesis: evidence for bulge epithelial expression and persistence of dermal melanoblasts
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Aged Skin Cells Nurture Stem Cells toward Regeneration
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Gray Hair: From Preventive to Treatment
- Discrimination of Dysplastic Nevi from Common Melanocytic Nevi by Cellular and Molecular Criteria
- Keratin intermediate filaments in the colon: guardians of epithelial homeostasis
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Autophagy: Guardian of Skin Barrier
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Imaging to study solid tumour origin and progression: lessons from research and clinical oncology
- Research Techniques Made Simple: Zebrafish Models for Human Dermatologic Disease
- Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches
- Human Pigmentation: A Review of Molecular Mechanisms, Genetic Architecture, Evolution, Forensic DNA Phenotyping and Health Implications
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Uncovering novel biomarkers and drug targets for androgenetic alopecia via metabolite regulation and multi-tissue validation
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- Clinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups: A Retrospective Observational Study
- Prophylaxis and Management of Skin Toxicities
- Melanocytes in regenerative medicine applications and disease modeling
- N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma
- Metabolic Regulation of Hematopoietic Stem Cells in the Hypoxic Niche
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis